Publication for MAGEA1 and PRAME

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	MAGEA1	MAGE family member A1	4100			[link]
hsa	PRAME	PRAME nuclear receptor transcriptional regulator	23532

Pubmed ID	Priority	Text
27323861	0.97	MAGE-A1, MAGE-A2, MAGE-A3, MAGE-A4, MAGE-A6, MAGE-A10, MAGE-A12, MUC-1, NY-ESO-1, PRAME, p53, TPBG, TRT, WT1) in 4 established ovarian cancer cell lines and in primary tumor cells isolated from the high-grade serous epithelial ovarian cancer tissue.
	0.97	MAGE-A1, MAGE-A2, MAGE-A3, MAGE-A4, MAGE-A6, MAGE-A10, MAGE-A12, MUC-1, NY-ESO-1, PRAME, p53, TPBG, TRT and WT1, on isolated serous epithelial ovarian cancer cells and compared the obtained data to the expression profiles of 4 estabilished ovarian cancer cell lines, OV-90, SKOV-3 OVCAR-3 and CAOV-3.
	0.95	MAGE-A1, MAGE-A2, MAGE-A3, MAGE-A4, MAGE-A6, MAGE-A10, MAGE-A12 NY-ESO-1, PRAME, p53, TPBG, TRT, WT-1) in cancer cell lines, primary tumor cells and control ovarian tissue (C01 - C06)
31262361	0.96	MAGE-A1, after priming with U266B cells, and 2) PRAME, after priming with ICAM-1/KG-1 cells, were identified (Fig. 4aiii and biii).
26558755	0.95	MAGEA1, MAGEA12, IL8, FOXD1, IL1B, POSTN, PRAME, MMP9, SERPINE and CTGF.
32042403	0.92	MAGEA1, PRAME, PASD1, and SSX1, since genes encoding them expressed more often than others.
	0.85	MAGEA1, PASD1, PRAME in melanoma cell lines were significantly higher than in STBS group (adj.
	0.81	MAGEA1 in half of the cultures, and high expression of PRAME.
	0.81	MAGEA1 (25% 1/4), NYESO1 (50% 2/4), and PRAME (75% 3/4) genes were also found in the cells of four samples of synovial sarcomas.
	0.63	MAGEA1 (60% 3/5), PRAME (40% 2/5), NY-ESO1 (40% 2/5), PASD1 (60% 3/5), SLLP1 (60% 3/5), SSX1 (80% 4/5).
24457462	0.76	MAGEA1, ACRBP, PRAME, and SSX2 and staining was assessed for intensity (1-2+) and percent tumor positivity.
	0.76	PRAME, SSX2, and MAGEA1 in addition to the increased gene transcription of PRAME and CTAG2 (LAGE-1) in myxoid and round cell liposarcomas.
	0.74	MAGEA1, ACRBP, PRAME, and SSX2 by immunohistochemistry and PRAME, CTAG2, and MAGEA3 by quantitative real-time PCR.
	0.70	MAGEA1, ACRBP, PRAME, and SSX2 in myxoid and round-cell liposarcoma by immunohistochemistry in addition to determining mRNA levels of CTAG2 (LAGE-1), PRAME, and MAGEA3 by quantitative real-time PCR.
25914874	0.74	MAGE-1, MAGE-3, MAGE-C2, MAGE-C1, MAGE-A1, MAGE-A3, PRAME, NY-ESO-1, SSX1, SSX4, SSX5, SSX2, BAGE, ADAM2, LIPI, Dickkof-1, hTERT, CD138, XBP1, CS1, WT1, survivin, and BCMA.
24764584	0.54	PRAME, ACTL8, and MAGEA3 (Figure 2B) and the expression of MAGEA1, 3, 4, 12 and CSAG1 is higher in magnoid lung adenocarcinomas (Figure 2C right panel).